Karyopharm announces planned merger with Ayrmid amid Chapter 11 bankruptcy filing
The merger is not final and other companies will be able to bid for Karyopharm’s assets
Read More
Section: Regulatory
MHRA approves new oral treatment for moderate-to-severe plaque psoriasis
Plaque psoriasis is an inflammatory condition that causes red, scaly and often itchy or painful patches of skin
Read More
Roche’s fenebrutinib receives FDA filing acceptance for relapsing and primary progressive MS
If approved, this treatment would offer a new option for the nearly one million Americans living with MS
Read More
Ogsiveo recommended by NICE to treat rare soft tissue tumours
Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues
Read More
Lilly gets FDA approval for severe alopecia areata treatment for paediatric patients
Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes
Read More